Shares of Avacta Group Plc (LON:AVCT – Get Rating) crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 112.88 ($1.33) and traded as low as GBX 108.50 ($1.28). Avacta Group shares last traded at GBX 110.60 ($1.31), with a volume of 827,403 shares traded.
Avacta Group Price Performance
The company’s 50-day moving average price is GBX 110.55 and its 200-day moving average price is GBX 112.87. The company has a debt-to-equity ratio of 13.42, a current ratio of 5.00 and a quick ratio of 4.96. The company has a market cap of £290.63 million and a P/E ratio of -10.57.
Avacta Group Company Profile
Avacta Group Plc, a clinical stage biopharmaceutical company, develops cancer therapies and diagnostics based on its proprietary Affimer and pre|CISION platforms in the United Kingdom, North America, South Korea, and rest of Asia and Europe. It operates through Diagnostics and Therapeutics segments. The company develops custom Affimer proteins for customer products and in-house diagnostic assays.
- Is the 60/40 Portfolio Mix Still in Vogue?
- Salesforce Cuts Labor, Shows Strong Earnings Despite Challenges
- Microsoft Shares: Is it Time to Back Up the Truck?
- Institutional Support for Analog Devices Remains High
- Three CBD Stocks to Dominate a Budding Industry
Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.